Literature DB >> 19669259

Hepatitis E vaccine.

Rakesh Aggarwal1, Shahid Jameel.   

Abstract

Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2 billion people live in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant subunit vaccines based on the viral capsid protein. This review summarizes these efforts.

Entities:  

Year:  2008        PMID： 19669259      PMCID： PMC2716888          DOI： 10.1007/s12072-008-9071-4

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


  61 in total

1.  Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.

Authors:  Masahiro Niikura; Shiki Takamura; Gisen Kim; Satoru Kawai; Masayuki Saijo; Shigeru Morikawa; Ichiro Kurane; Tian-Cheng Li; Naokazu Takeda; Yasuhiro Yasutomi
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

2.  Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China.

Authors:  T T Aye; T Uchida; X Z Ma; F Iida; T Shikata; H Zhuang; K M Win
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

3.  Role of long-persisting human hepatitis E virus antibodies in protection.

Authors:  A Chauhan; J B Dilawari; R Sharma; M Mukesh; S R Saroa
Journal:  Vaccine       Date:  1998-04       Impact factor: 3.641

4.  Immunoprophylaxis of epidemic non-A non-B hepatitis.

Authors:  Y K Joshi; S Babu; S Sarin; B N Tandon; B M Gandhi; V C Chaturvedi
Journal:  Indian J Med Res       Date:  1985-01       Impact factor: 2.375

5.  A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus.

Authors:  S W Im; J Z Zhang; H Zhuang; X Y Che; W F Zhu; G M Xu; K Li; N S Xia; M H Ng
Journal:  Vaccine       Date:  2001-06-14       Impact factor: 3.641

6.  Hepatitis E virus: identification of type-common epitopes.

Authors:  P O Yarbough; A W Tam; K E Fry; K Krawczynski; K A McCaustland; D W Bradley; G R Reyes
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Perspectives of vaccination against hepatitis E.

Authors:  A Safary
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

8.  Safety and efficacy of a recombinant hepatitis E vaccine.

Authors:  Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

9.  Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid.

Authors:  Shao-Wei Li; Jun Zhang; Zhi-Qiang He; Ying Gu; Ru-Shi Liu; Jian Lin; Yi-Xin Chen; Mun-Hon Ng; Ning-Shao Xia
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

10.  Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.

Authors:  Hong-Zhao Li; Hong-Ying Gang; Qiang-Ming Sun; Xiao Liu; Yan-Bing Ma; Mao-Sheng Sun; Chang-Bai Dai
Journal:  Chin Med Sci J       Date:  2004-06
View more
  13 in total

1.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences.

Authors:  Claro Yu; Denali Boon; Shannon L McDonald; Timothy G Myers; Keiko Tomioka; Hanh Nguyen; Ronald E Engle; Sugantha Govindarajan; Suzanne U Emerson; Robert H Purcell
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  RNA interference induces effective inhibition of mRNA accumulation and protein expression of SHEV ORF3 gene in vitro.

Authors:  Tao Liu; Ming Lei; Hanwei Jiao; Li Du; Ying Cheng; Donglin Zhang; Yongchang Hao; Churiga Man; Fengyang Wang
Journal:  Curr Microbiol       Date:  2011-01-12       Impact factor: 2.188

4.  The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex.

Authors:  Vivek Chandra; Manjula Kalia; Krishnan Hajela; Shahid Jameel
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

5.  Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin M.

Authors:  Jin-Shun Pan; Kui Zhang; Jinyong Zhou; Chao Wu; Hui Zhuang; Yi-Hua Zhou
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

6.  Fatal hepatitis E viral infection in pregnant women in Ghana: a case series.

Authors:  Joseph Humphrey Kofi Bonney; Robert A Kwame-Aryee; Samuel Obed; Ama Asantewa Tamatey; Jacob Samson Barnor; Naa Baake Armah; Samuel Antwi Oppong; Mubarak Osei-Kwesi
Journal:  BMC Res Notes       Date:  2012-09-03

7.  Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF.

Authors:  Shikha Taneja; Imran Ahmad; Somdutta Sen; Saravanan Kumar; Reena Arora; Vijay K Gupta; Rakesh Aggarwal; Krishnamoorthy Narayanasamy; Vanga S Reddy; Shahid Jameel
Journal:  Proteome Sci       Date:  2011-02-04       Impact factor: 2.480

8.  The hepatitis E virus ORF3 protein regulates the expression of liver-specific genes by modulating localization of hepatocyte nuclear factor 4.

Authors:  Vivek Chandra; Prasida Holla; Dhrubaa Ghosh; Debarshi Chakrabarti; Muralidhara Padigaru; Shahid Jameel
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

9.  Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.

Authors:  Yan Gao; Qiudong Su; Yao Yi; Zhiyuan Jia; Hao Wang; Xuexin Lu; Feng Qiu; Shengli Bi
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

10.  Novel hepatitis E like virus found in Swedish moose.

Authors:  Jay Lin; Heléne Norder; Henrik Uhlhorn; Sándor Belák; Frederik Widén
Journal:  J Gen Virol       Date:  2013-12-02       Impact factor: 3.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.